Novo A/S announces the proposed acquisition of a 19.95% shareholding in ConvaTec Group Plc

Novo A/S announces the proposed acquisition of a 19.95% shareholding in ConvaTec Group Plc, a UK listed global medical products and technologies company with leading market positions in advanced wound care, ostomy care, continence and critical care and infusion devices. At completion of the transaction, Kasim Kutay, CEO of Novo A/S, will join the Board of Directors of ConvaTec Group Plc.